Literature DB >> 31897576

Effects of chronic silencing of relaxin-3 production in nucleus incertus neurons on food intake, body weight, anxiety-like behaviour and limbic brain activity in female rats.

Camila de Ávila1,2,3, Sandrine Chometton4, Sherie Ma5,6, Lola Torz Pedersen7, Elena Timofeeva4, Carlo Cifani4,8, Andrew L Gundlach9.   

Abstract

Eating disorders are frequently triggered by stress and are more prevalent in women than men. First signs often appear during early adolescence, but the biological basis for the sex-specific differences is unknown. Central administration of native relaxin-3 (RLN3) peptide or chimeric/truncated analogues produces differential effects on food intake and HPA axis activity in adult male and female rats, but the precise role of endogenous RLN3 signalling in metabolic and neuroendocrine control is unclear. Therefore, we examined the effects of microRNA-induced depletion (knock-down) of RLN3 mRNA/(peptide) production in neurons of the brainstem nucleus incertus (NI) in female rats on a range of physiological, behavioural and neurochemical indices, including food intake, body weight, anxiety, plasma corticosterone, mRNA levels of key neuropeptides in the paraventricular nucleus of hypothalamus (PVN) and limbic neural activity patterns (reflected by c-fos mRNA). Validated depletion of RLN3 in NI neurons of female rats (n = 8) produced a small, sustained (~ 2%) decrease in body weight, an imbalance in food intake and an increase in anxiety-like behaviour in the large open field, but not in the elevated plus-maze or light/dark box. Furthermore, NI RLN3 depletion disrupted corticosterone regulation, increased oxytocin and arginine-vasopressin, but not corticotropin-releasing factor, mRNA, in PVN, and decreased basal levels of c-fos mRNA in parvocellular and magnocellular PVN, bed nucleus of stria terminalis and the lateral hypothalamic area, brain regions involved in stress and feeding. These findings support a role for NI RLN3 neurons in fine-tuning stress and neuroendocrine responses and food intake regulation in female rats.

Entities:  

Keywords:  Anxiety; Feeding; Female rats; Nucleus incertus; Relaxin-3; Stress

Mesh:

Substances:

Year:  2020        PMID: 31897576     DOI: 10.1007/s00213-019-05439-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  61 in total

1.  Restricted, but abundant, expression of the novel rat gene-3 (R3) relaxin in the dorsal tegmental region of brain.

Authors:  Tanya C D Burazin; Ross A D Bathgate; Mary Macris; Sharon Layfield; Andrew L Gundlach; Geoffrey W Tregear
Journal:  J Neurochem       Date:  2002-09       Impact factor: 5.372

Review 2.  Minireview: glucocorticoids--food intake, abdominal obesity, and wealthy nations in 2004.

Authors:  Mary F Dallman; Susanne E la Fleur; Norman C Pecoraro; Francisca Gomez; Hani Houshyar; Susan F Akana
Journal:  Endocrinology       Date:  2004-03-24       Impact factor: 4.736

3.  Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation.

Authors:  Avantika Banerjee; Pei-Juan Shen; Sherie Ma; Ross A D Bathgate; Andrew L Gundlach
Journal:  Neuropharmacology       Date:  2009-06-26       Impact factor: 5.250

4.  Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene. Novel members of the relaxin peptide family.

Authors:  Ross A D Bathgate; Chrishan S Samuel; Tanya C D Burazin; Sharon Layfield; Antonia A Claasz; Irna Grace T Reytomas; Nicola F Dawson; Chongxin Zhao; Courtney Bond; Roger J Summers; Laura J Parry; John D Wade; Geoffrey W Tregear
Journal:  J Biol Chem       Date:  2001-10-31       Impact factor: 5.157

Review 5.  The Human BNST: Functional Role in Anxiety and Addiction.

Authors:  S N Avery; J A Clauss; J U Blackford
Journal:  Neuropsychopharmacology       Date:  2015-06-24       Impact factor: 7.853

Review 6.  The mouse light/dark box test.

Authors:  Michel Bourin; Martine Hascoët
Journal:  Eur J Pharmacol       Date:  2003-02-28       Impact factor: 4.432

7.  Differential effects of relaxin-3 and a selective relaxin-3 receptor agonist on food and water intake and hypothalamic neuronal activity in rats.

Authors:  Camila de Ávila; Sandrine Chometton; Christophe Lenglos; Juliane Calvez; Andrew L Gundlach; Elena Timofeeva
Journal:  Behav Brain Res       Date:  2017-08-31       Impact factor: 3.332

8.  Differential effects of central administration of relaxin-3 on food intake and hypothalamic neuropeptides in male and female rats.

Authors:  J Calvez; C Lenglos; C de Ávila; G Guèvremont; E Timofeeva
Journal:  Genes Brain Behav       Date:  2015-08-18       Impact factor: 3.449

9.  Role of relaxin-3/RXFP3 system in stress-induced binge-like eating in female rats.

Authors:  Juliane Calvez; Camila de Ávila; Louis-Olivier Matte; Geneviève Guèvremont; Andrew L Gundlach; Elena Timofeeva
Journal:  Neuropharmacology       Date:  2015-11-30       Impact factor: 5.250

10.  Silencing relaxin-3 in nucleus incertus of adult rodents: a viral vector-based approach to investigate neuropeptide function.

Authors:  Gabrielle E Callander; Sherie Ma; Despina E Ganella; Verena C Wimmer; Andrew L Gundlach; Walter G Thomas; Ross A D Bathgate
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

View more
  3 in total

Review 1.  The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease.

Authors:  Hanne Leysen; Deborah Walter; Lore Clauwaert; Lieselot Hellemans; Jaana van Gastel; Lakshmi Vasudevan; Bronwen Martin; Stuart Maudsley
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

2.  Investigation of Relaxin-3 Serum Levels in terms of Social Interaction, Communication, and Appetite as a Biomarker in Children with Autism.

Authors:  Semih Erden; Kevser Nalbant; İbrahim Kılınç
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-02-28       Impact factor: 2.582

Review 3.  Anxiety and Depression: What Do We Know of Neuropeptides?

Authors:  Ida Kupcova; Lubos Danisovic; Ivan Grgac; Stefan Harsanyi
Journal:  Behav Sci (Basel)       Date:  2022-07-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.